Literature DB >> 11726911

The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations.

K Furukawa1, H Ohteki, K Hirahara, Y Narita, S Koga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11726911     DOI： 10.1067/mtc.2001.116940

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  11 in total

1.  Intraoperative infusion of epoprostenol sodium for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.

Authors:  Keisuke Yamamoto; Ryuzo Sakata; Yoshifumi Iguro; Tetsuya Ueno; Masahiro Ueno; Takayuki Ueno
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-08

Review 2.  Thrombin inhibitors and cardiopulmonary bypass.

Authors:  Alan Merry
Journal:  J Extra Corpor Technol       Date:  2006-03

3.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

4.  Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation.

Authors:  Yoshinori Tanigawa; Tomoko Yamada; Koichi Matsumoto; Akira Nakagawachi; Arisu Torikai; Yoshirou Sakaguchi
Journal:  J Anesth       Date:  2013-05-16       Impact factor: 2.078

Review 5.  [Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia].

Authors:  S A Kozek-Langenecker
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041

6.  Emergency pulmonary embolectomy during the second trimester of pregnancy: report of a case.

Authors:  Satoshi Taniguchi; Ikuo Fukuda; Masahito Minakawa; Ken-Ichi Watanabe; Kazuyuki Daitoku; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

7.  Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass.

Authors:  Shvetank Agarwal; Beth Ullom; Yasser Al-Baghdadi; Michael Okumura
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-01

8.  An Anti-Coagulation Conundrum: Implantation of Total Artificial Heart in a Patient with Heparin-Induced Thrombocytopenia Type II.

Authors:  Theodore J Cios; Yuliana Salamanca-Padilla; Dmitri Guvakov
Journal:  Am J Case Rep       Date:  2017-03-23

9.  Use of argatroban in combination with nafamostat mesilate in open-heart surgery for a pediatric patient with heparin-induced thrombocytopenia type II: a case report.

Authors:  Shuji Kawamoto; Eriko Kusudo; Kazuhiko Fukuda
Journal:  JA Clin Rep       Date:  2020-01-13

10.  Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.

Authors:  Rebecca L Morgan; Vahid Ashoorion; Adam Cuker; Housne Begum; Stephanie Ross; Nina Martinez; Beng H Chong; Lori A Linkins; Theodore E Warkentin; Wojtek Wiercioch; Robby Nieuwlaat; Holger Schünemann; Nancy Santesso
Journal:  Blood Adv       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.